Cite
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
MLA
Rosenthal, David I., et al. “Association of Human Papillomavirus and P16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 34, no. 12, Apr. 2016, pp. 1300–08. EBSCOhost, https://doi.org/10.1200/JCO.2015.62.5970.
APA
Rosenthal, D. I., Harari, P. M., Giralt, J., Bell, D., Raben, D., Liu, J., Schulten, J., Ang, K. K., & Bonner, J. A. (2016). Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34(12), 1300–1308. https://doi.org/10.1200/JCO.2015.62.5970
Chicago
Rosenthal, David I, Paul M Harari, Jordi Giralt, Diana Bell, David Raben, Joyce Liu, Jeltje Schulten, Kian K Ang, and James A Bonner. 2016. “Association of Human Papillomavirus and P16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34 (12): 1300–1308. doi:10.1200/JCO.2015.62.5970.